Case report: Use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia

By afschroeder • October 2, 2025

Ramakrishnan A, Olitsky S, Saggar R, Channick RN, McWilliams JP. Case report: Use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia. Respir Med Case Rep. 2025 Sep 16;58:102291. doi: 10.1016/j.rmcr.2025.102291. PMID: 41030324; PMCID: PMC12477927.

Tags: Epistaxis, Hereditary hemorrhagic telangiectasia, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, Sotatercept

Stress Trajectory and Hypertension 2 to 7 Years After Delivery: A nuMoM2b-HHS Study

Nuckols VR, Barone Gibbs B, Brewer BC, Gaffey AE, Greaney JL, Patterson F, Greenland P, Saade GR, Grobman WA, Yee LM, Bairey Merz CN, Chung[...]

Incidence and predictors of postoperative recall of propofol injection pain: a prospective observational cohort pilot study

Bellouni G, Clanet M, Touihri K, Delaporte A, Boulos NM, Kim K, Grogan T, Alexander B, Coeckelenbergh S, Joosten A. Incidence and predictors of postoperative[...]

From Insight to Impact: Advancing Learning Health System Capability Through a System-Wide Quality Improvement Symposium

Dermenchyan A, Seiden DS, Bhayani M, Song A, Venkatesan N, Sharma K, Pandrangi K, Han MA. From Insight to Impact: Advancing Learning Health System Capability[...]